Pain from intraocular injections with ultrathin needles compared to regular needles.

Pain experienced from intravitreal injection with a 33 gauge needle vs a 30 gauge needle: is thinner better?

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON29404

Enrollment

Registered

2013-01-04

Start date

2013-01-10

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intravitreal, intraocular, injection, pain, crossover. intravitreaal, intraoculair, injectie, pijn.

Interventions

Two consecutive intraocular bevacizumab injections with a 33G and 30G needle.

Eligibility

Inclusion criteria

Inclusion criteria: Patients with an indication for at least two consecutive monthly intravitreal injections with bevacizumab.

Exclusion criteria

Exclusion criteria: Patients unable to state pain levels or give written informed consent.

Design outcomes

Primary

Measure	Time frame
Pain score on 100mm numeric rating scale.	—

Secondary

Measure	Time frame
Patients’ stress levels and expectation questionnaire scores.	—

Contacts

Public ContactF. Asten, van

Philips van Leydenlaan 15

F.vanAsten@ohk.umcn.nl+31 (0)24 3610241

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)